Estriol
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
DOWNLOAD PDF HERE
1 DEFINITION
Estriol contains NLT 97.0% and NMT 102.0% of estriol (C18H24O3), calculated on the dried basis.
2 IDENTIFICATION
Change to read:
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K. (CN 1-May-2020) Meets the requirements
Change to read:
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. (USP 1-May-2019)
3 ASSAY
Change to read:
Procedure
Solution A: Water
Solution B: Methanol
Mobile phase: See Table 1.
Table 1
Time (min) | Solution A (%) | Solution B (%) |
| 0.0 | 65 | 35 |
| 3.0 | 65 | 35 |
| 14.0 | 56 | 44 |
| 17.0 | 10 | 90 |
| 17.1 | 65 | 35 |
| 20.0 | 65 | 35 |
Diluent: Methanol and water (1:1)
System suitability solution: 100 μg/mL of USP Estriol RS and 5 μg/mL of USP Estriol Related Compound A RS in Diluent. Sonicate to dissolve as needed.
Standard solution: 100 μg/mL of USP Estriol RS in Diluent. Sonicate to dissolve as needed.
Sample solution: 100 μg/mL of Estriol in Diluent. Sonicate to dissolve as needed.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 220 nm
Column: 4.6-mm × 15-cm; 2.6-μm packing L1
Column temperature: 32°
Flow rate: 1.0 mL/min
Injection volume: 25 μL
System suitability
Samples: System suitability solution and Standard solution
[Note—See Table 2 for the relative retention times.]
Suitability requirements
Resolution: NLT 1.2 between estriol related compound A and estriol, System suitability solution
Tailing factor: NMT 1.5, Standard solution
Relative standard deviation: NMT 0.73%, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of estriol (C18H24O3) in the portion of Estriol taken:
Result = (rU/rS) × (CS/CU) × 100
rU= peak response from the Sample solution
rS = peak response from the Standard solution
CS = concentration of USP Estriol RS in the Standard solution (μg/mL)
CU = concentration of Estriol in the Sample solution (μg/mL)
(USP 1-May-2019)
Acceptance criteria: 97.0%–102.0% on the dried basis
4 IMPURITIES
Residue on Ignition 〈281〉: NMT 0.1%
Change to read:
Organic Impurities
Solution A, Solution B, Diluent, and Chromatographic system: Proceed as directed in the Assay.
Mobile phase: See Table 2.
Table 2
Time (min) | Solution A (%) | Solution B (%) |
| 0.0 | 65 | 35 |
| 3.0 | 65 | 35 |
| 40.0 | 35 | 65 |
| 41.0 | 65 | 35 |
| 45.0 | 65 | 35 |
System suitability stock solution A: 200 μg/mL of USP Estriol RS prepared as follows. Transfer a suitable quantity of USP Estriol RS to an appropriate volumetric flask. Add 50% of the total flask volume of methanol to dissolve, and sonicate to fully dissolve the solids. Dilute with water to volume and mix well.
System suitability stock solution B: 100 μg/mL each of USP Estriol Related Compound A RS, USP Estrone RS, and USP Estradiol RS prepared flas follows. Transfer a suitable quantity of each Reference Standard to an appropriate volumetric flask. Add 80% of the total flask volume of methanol to dissolve, and sonicate to fully dissolve the solids. Dilute with methanol to volume and mix well.
System suitability solution: 100 μg/mL of USP Estriol RS and 5 μg/mL each of USP Estriol Related Compound A RS, USP Estrone RS, and USP Estradiol RS prepared as follows. Transfer 10-mL of System suitability stock solution A into a 20-mL volumetric flask. Add 1 mL of System suitability stock solution B and 1 mL of water. Dilute with Diluent to volume and mix well. Sonicate to dissolve as needed.
Standard solution: 0.4 μg/mL of USP Estriol RS and 2 μg/mL each of USP Estriol Related Compound A RS, USP Estrone RS, and USP Estradiol RS in Diluent. Sonicate to dissolve as needed.
Sample solution: 400 μg/mL of Estriol prepared as follows. Transfer a suitable quantity of Estriol to an appropriate volumetric flask. Add 50% of the total flask volume of methanol to dissolve, and sonicate to fully dissolve the solids. Dilute with water to volume and mix well.
System suitability
Samples: System suitability solution and Standard solution
[Note—See Table 3 for the relative retention times.]
Suitability requirements
Resolution: NLT 1.2 between estriol related compound A and estriol; NLT 1.2 between estrone and estradiol, System suitability solution
Relative standard deviation: NMT 10.0%; estriol, estriol related compound A, estrone, and estradiol, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of estriol related compound A, estrone, and estradiol in the portion of Estriol taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of estriol related compound A, estrone, or estradiol from the Sample solution
rS = peak response of the corresponding USP Reference Standard from the Standard solution
CS = concentration of the corresponding USP Reference Standard in the Standard solution (μg/mL)
CU = concentration of Estriol in the Sample solution (μg/mL)
Calculate the percentage of any individual impurity in the portion of Estriol taken:
Result = (rU/rS) × (CS /CU) × 100
rU = peak response of any individual impurity from the Sample solution
rS= peak response of estriol from the Standard solution
CS = concentration of USP Estriol RS in the Standard solution (μg/mL)
CU = concentration of Estriol in the Sample solution (μg/mL)
Acceptance criteria: See Table 3.
Table 3
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
| 16β,17α-Estriola | 0.94 | 0.5 |
| Estriol related compound A | 0.97 | 0.5 |
| Estriol | 1.00 | - |
| 16β-Estriolb | 1.53 | 0.5 |
| 17α-Estriolc | 1.60 | 0.5 |
| Estrone | 2 30 | 0.5 |
| Estradiol | 2.34 | 0.5 |
| 3-O-Methyl estriold | 2.64 | 0.5 |
| Any individual unspecified impurity | - | 0.10 |
| Total impuritiese | - | 1 |
a Estra-1,3,5(10)-triene-3,16β,17α-triol.
b Estra-1,3,5(10)-triene-3,16β,17β-triol.
c Estra-1,3,5(10)-triene-3,16α,17α-triol.
d 3-Methoxy-(16α,17β)-estra-1,3,5(10)-triene-16,17-diol.
e Total impurities exclude estriol related compound A.
(USP 1-May-2019)
5 SPECIFIC TESTS
Optical Rotation 〈781S〉, Procedures, Specific Rotation
Sample solution: 4 mg/mL, in dioxane
Acceptance criteria: +54° to +62°
Loss on Drying 〈731〉
Analysis: Dry at 105° for 3 h.
Acceptance criteria: NMT 0.5% of its weight
Delete the following:
Completeness of Solution
Sample solution: 50 mg/mL in pyridine
Acceptance criteria: The solution is clear and free from undissolved solid. (USP 1-May-2019)
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight containers.
Change to read:
USP Reference Standards 〈11〉
USP Estradiol RS (USP 1-May-2019)
USP Estriol RS
USP Estriol Related Compound A RS
Estra-1,3,5(10),9(11)-tetraene-3,16α,17β-triol.
C18H22O3 286.37
USP Estrone RS
(USP 1-May-2019)

